WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for Ionis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-08 10:52 am Purchase |
2024-09-30 | 13G | Ionis Pharmaceuticals, Inc. IONS |
WELLINGTON MANAGEMENT CO LLP | 9,067,836 5.760% |
2,319,282 (+34.37%) |
Filing |